Injective (INJ) is currently trading at $3.06, reflecting a slight decline of 0.34% over the past 24 hours. The price has fluctuated between a daily high of $3.10 and a low of $3.01, indicating relatively tight trading conditions with a daily range of just 0.09%.

Trading volume stands at approximately $27.91 million, with a volume-to-market cap ratio of 9.13%. This suggests moderate liquidity, although the price change over the past 24 hours indicates some caution among traders.

The short-term moving averages (8 SMA at $3.03 and 13 SMA at $3.03) show a bullish sentiment with increases of 1.10% and 1.06% respectively. However, the 55 SMA at $3.07 is showing a slight decline of 0.37%, indicating potential resistance in the near term.

The 1-hour RSI is currently at 64, suggesting that INJ is approaching overbought territory, while the 7-day RSI at 55 indicates a neutral market condition. The 7-day price change of 8.51% demonstrates a recent bullish trend, although the 14-day price change of -2.76% reflects some underlying weakness.

Given the price action and technical indicators, there appears to be a mix of bullish and bearish signals. The presence of a recent upward trend over the last week is positive, but the overall resistance indicated by the longer-term moving averages and the higher RSI suggests caution.

Overall, Injective (INJ) shows potential for short-term trading gains, but the mixed signals warrant careful monitoring. Based on the analysis of technical indicators and recent price movements, the recommendation is to Hold, as potential upward momentum exists, but risk factors from resistance levels and RSI position must be accounted for.